The US Food and Drug Administration's (FDA) Office of Prescription Drug Promotion (OPDP) has issued an untitled letter—its third in 2018—to Arog Pharmaceuticals over promotional claims for its ...
DALLAS, Nov. 2, 2015 (GLOBE NEWSWIRE) -- Arog Pharmaceuticals, Inc., a privately held, clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs to ...
DALLAS, Dec. 01, 2017 (GLOBE NEWSWIRE) -- Arog Pharmaceuticals, Inc., a privately held, clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs to ...
Privately held Arog Pharmaceuticals Inc. won orphan drug status in Europe for crenolanib to treat acute myeloid leukemia (AML) and soft-tissue sarcoma. An orally available benzimidazole, crenolanib is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results